 |
Loxo Oncology
Last updated: February 25, 2024
Jacob S. Van Naarden Chief Business Officer and CEO Joshua Bilenker
Country: USA | Funding: $506M (+)
Website: http://www.loxooncology.com/
Loxo Oncology is innovating the development of highly selective medicines for patients with genetically defined cancers.
Website: http://www.loxooncology.com/
Loxo Oncology is innovating the development of highly selective medicines for patients with genetically defined cancers.
